Abstract
After implanting a CRT device, consistent and scheduled patient follow-up is mandatory. Besides determining electrode parameters and reviewing arrhythmic episodes, these follow-ups focus on monitoring and optimizing congestive heart failure therapy. Therefore new CRT devices present methods for heart failure surveillance and telemetric transmission of the acquired data, which allows the physician to respond immediately to the varying needs of the respective heart failure patient. In addition to cardiac resynchronization, optimization of atrioventricular (AV) and interventricular (VV) delay provide major hemodynamic benefits. As echocardiographic optimization of AV and VV delay is time consuming it is often not feasible during daily clinical practice. Therefore implemented algorithms that automatically determine and adapt AV and VV delays with respect to the fluctuating needs of the patients are essential. This article presents the current state of monitoring and optimization methods in CRT devices.
Zusammenfassung
Patienten, die mit einem CRT-System versorgt werden, bedürfen einer konsequenten und regelmäßigen Nachsorge. Diese umfasst nicht nur die elektrischen Parameter der Elektroden und die Auswertung kardialer Arrhythmie-Episoden, sondern besonders die Kontrolle und Optimierung der Therapie einer sich beständig variierenden Herzinsuffizienz. Neuere Anwendungen der CRT-Systeme überwachen den klinischen Verlauf des Patienten und versenden die erhobenen Befunde ganz oder teilweise telemetrisch an den behandelnden Arzt, der so schon frühzeitig therapeutische Konsequenzen einleiten kann.
Weitere implementierte Algorithmen dienen der Optimierung dieser Systeme. Neben der Resynchronisation der kardialen Kontraktion ist die Optimierung der atrioventrikulären (AV)- und interventrikulären (VV)-Überleitungszeit für den Füllungszustand beider Ventrikel von entscheidender Bedeutung. Diese Optimierung erfolgt bislang überwiegend echokardiographisch, ist zeitaufwendig und untersucherabhängig. Für die klinische Praxis sind deshalb CRT-Systeme mit implementierten Algorithmen sinnvoll, welche die AV- und VV-Zeiten rezidivierend und individuell, abhängig vom aktuellen Stadium der Herzinsuffizienz anpassen. Dieser Artikel gibt eine Übersicht der aktuell vorhandenen Überwachungs- und Optimierungssysteme für CRT-Geräte.
Similar content being viewed by others
Literatur
Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549
Young JB, Abraham Wt, Smith AL et al (2003) Multicenter InSync ICD randomized clinical evaluation (MIRACLE ICD) trial investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289(20):2685–2694
Cazeau S, Leclercq C, Lavergne T et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880
Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853
Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150
Linde C, Leclercq C, Rex S et al (2002) Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40(1):111–118
Boriani G, Müller CP, Seidl KH et al (2006) Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy: the resynchronization for the hemodynamic treatment for heart failure management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Am Heart J 151:1050–1058
Yu CM, Hong-Fung JW, Zhang Q et al (2005) Understanding nonresponders of cardiac resynchronization therapy – current and future perspectives. J Cardiovasc Electrophysiol. Vol 16, pp 1117–1124
Auricchio A, Ding J, Spinelli JC, Kramer AP, Salo RW, Hoersch W, Ken-Knight BH, Klein HU (2002) Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. J Am Coll Cardiol 39:1163–1169
Auricchio A, Stellbrink C, Block M et al (1999) Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 99:2993–3001
Bordachar P, Lafitte S, Reuter S et al (2004) Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing. JACC 44(11):2157–2165
Van Gelder BM, Bracke FA, Meijer A et al (2004) Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy american journal of cardiology 93:1500–1503
Sogaard P, Egelbad H, Petersen A et al (2002) Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue doppler imaging. Circulation 106:2078–2084
Coletta AP, Nikitin N, Clark AL, Cleland JG (2003) Clinical trials update from the American heart association meeting. PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure. Eur J Heart Fail 5(1):95–99
Bondmass M et al (2001) J Am Coll Cardiol 37:1A–648A
Schoenfeld MH, Compton SJ, Mead RH et al (2004) Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pace 27(6 Pt 1):757–763
Nolan J, Batin PD, Andrews R et al (1998) Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation 98(15):1510–1516
Fauchier L, Babuty D, Melin A et al (2004) Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances. Eur J Heart Fail 6(2):181–185
Rashba EJ, Estes NA, Wang P et al (2006) Preserved heart rate variability identifies low risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm 3(3):281–286
Adamson PB, Smith AL, Abraham WT et al (2005) Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 110(16):2389–2394
Carlson G et al (1998) Prediction of exercise capacity in HF patients during pacing therapy using a new 2-D HRV parameter. Heart failure SA
Yu CM, Wang L, Chau E, Chan R, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP (2005) Intrathoracic impedance monitoring in patients with heart failure. Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112:841–848
Butter C, Wellnhofer E, Schlegel M (2004) Ein Vergleich der hämodynamisch optimierten AV-Zeit mit einem gerätebasiertem Programmiervorschlag in CRT Geräten. DGK, Mannheim
Gold MR Niazi I, Giudici M et al (2007) A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol 18:490–496
Padeletti L, Porciani C, Ritter P, Michelucci A, Colella A, Pieragnoli P, Costoli A, Ciapetti C, Sabini A, Demarchi G, Gensini GF (2000) Automatic optimization of resting and exercise atrioventricular interval using a peak endocardial acceleration sensor: validation with doppler echocardiography and direct cardiac output measurements. Vol 23, PACE
Dupuis JM, Mehreb M, Rouleau F, Lefthériotis G, Ritter P, Victor J (2003) Programming optimal atrioventricular delay in dual chamber pacing uising endocardial acceleration: comparison with a standard echocardiographic procedure. Vol 26, PACE
Bongiorni MG, Soldati E, Arena G et al (1996) Is local myocardial contractility related to endocardial acceleration signals detected by a transvenous pacing lead? PACE, 19(11):1682–1688
Leung SK, Lau CP, Tse-Fun Lam C, Ho S, Tse HF, Yu CM, Lee K, Tang MO, To KM (2000) Atrioventricular interval optimisation in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements. Vol 23, PACE, pp 1762–1766
Ritter P, Padeleltti L, Gillio-Meina L et al (1999) Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Vol 1, Europace, pp 126–130
Bordacher P, Garrique S, Reuter S et al (2000) Hemodynamic assessment of right, left and biventricular pacing by peak endocardial acceleration and echocardiography in patients with end stage heart failure. PACE 23(11):1726–1730
Garrique S, Bordachar P, Reuter S et al (2002) Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective hemodynamic study. Heart 87(6):529–534
Plicchi G, Marcelli E, Renesto F (2005) Variation of CRT response during follow up: assessment and reprogramming, Vol 7. Europace Supplements 11:299
Worley SJ, Gohn DC, Smith TM et al (2004) Optimization of cardiac resynchronization: left atrial electrograms measured at implant eliminates the need for echo and identifies patients where AV optimization is not possible. Journal of Cardiac Failure. Vol 10, Issue 4, pp 62/160
Koglek W, Kranig W, Kowalski M et al (2000) Eine einfache Methode zur Bestimmung des AV-Intervalls bei Zweikammerschrittmachern. Herzschr Elektrophys 11:244–253
Meine M, Mueller C, Trappe HJ et al (2004) IEGM based method for estimating optimal VV delay in cardiac resynchronization therapy. Vol 6, Europace (Suppl):149/2
Min X, Meine M, Baker JH et al (2007) Estimation of the optimal VV-delay by an IEGM – Based method in cardiac resynchronization therapy. PACE 30:19–22
Stahl C, Beierlein W, Walker T et al (2007) Intracardiac impedance monitors hemodynamic deterioration in a chronic heart failure pig model. J Cardiovasc Electrophysiol 18(9):985–990
Bocchiardo M, Militello C, Azzaro G et al (2007) Intracardiac impedance optimizes AV- and VV-delay in heart failure patients. Heart Rhythm Society (Suppl 6):114
O'Donnel D, Nadurata V, Hamer A et al (2005) Long-term variations in optimal programming of cardiac resynchronization devices. PACE 28:24–26
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kloppe, A., Lemke, B. & Zarse, M. Neue Technologien zur Optimierung in der CRT-Programmierung. Herzschr. Elektrophys. 19, 19–29 (2008). https://doi.org/10.1007/s00399-008-0596-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00399-008-0596-y